SDHB IS OVEREXPRESSED AND MAY BE A CANDIDATE TARGET FOR THERAPEUTIC INTERVENTION IN MALIGNANT PLEURAL MESOTHELIOMA

被引：0
|
作者：
Jennings, Cormac J. [1 ]
Manente, Arcangela G. [2 ]
Marciniak, Stefan J. [3 ]
Pinton, Giulia [2 ]
Rassl, Doris M. [4 ]
Mutti, Luciano [5 ]
Thomas, Warren [1 ]
Rintoul, Robert C. [3 ]
Moro, Laura [2 ]
Byrne, Kenneth O. [6 ]
Gray, Steven G. [7 ]
机构：
[1] Royal Coll Surgeons Ireland, Dublin 2, Ireland
[2] Univ Piemonte Orientale, Dept Pharmacol Sci, Alessandria, Italy
[3] Univ Cambridge, CIMR, Cambridge CB2 1TN, England
[4] Papworth Hosp NHS Fdn Trust, Cambridge, England
[5] Vercelli Hosp, Vercelli, Italy
[6] Queensland Univ Technol, Canc & Ageing Res Program, Brisbane, Qld 4001, Australia
[7] Univ Dublin Trinity Coll, St James Hosp, Dublin 2, Ireland
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
SDHB; mesothelioma; mitochondria;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.02-013
引用
收藏
页码：S447 / S447
页数：1
相关论文
共 50 条
  • [31] Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma
    Otsuki, Takahiko
    Nakashima, Taku
    Hamada, Hironobu
    Takayama, Yusuke
    Akita, Shin
    Masuda, Takeshi
    Horimasu, Yasushi
    Miyamoto, Shintaro
    Iwamoto, Hiroshi
    Fujitaka, Kazunori
    Miyata, Yoshihiro
    Miyake, Masayuki
    Kohno, Nobuoki
    Okada, Morihito
    Hattori, Noboru
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (05)
  • [32] Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma
    Karnan, Sivasundaram
    Ota, Akinobu
    Murakami, Hideki
    Rahman, Lutfur
    Hasan, Muhammad Nazmul
    Wahiduzzaman
    Hanamura, Ichiro
    Lam Quang Vu
    Inoko, Akihito
    Hyodo, Toshinori
    Konishi, Hiroyuki
    Tsuzuki, Shinobu
    Hosokawa, Yoshitaka
    CELL DEATH DISCOVERY, 2020, 6 (01)
  • [33] RON receptor tyrosine kinase as a potential translational therapeutic target in malignant pleural mesothelioma
    Easty, D.
    Gray, S. G.
    Nonaka, D.
    Soltermann, A.
    Murer, B.
    Kennedy, M. J.
    Mutti, L.
    Pass, H. I.
    O'Donnell, D. M.
    O'Byrne, K. J.
    LUNG CANCER, 2010, 67 : S19 - S20
  • [34] Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma
    Sivasundaram, Karnan
    Ota, Akinobu
    Murakami, Hideki
    Hanamura, Ichiro
    Hyodo, Toshinori
    Konishi, Hiroyuki
    Tsuzuki, Shinobu
    Hosokawa, Yoshitaka
    CANCER SCIENCE, 2021, 112 : 629 - 629
  • [35] Prophylactic irradiation of intervention sites in malignant pleural mesothelioma
    Froment, Marie-Anne
    Frechette, Eric
    Dagnault, Anne
    RADIOTHERAPY AND ONCOLOGY, 2011, 101 (02) : 307 - 310
  • [36] Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
    Borea, Federica
    Franczak, Marika A.
    Garcia, Maria
    Perrino, Matteo
    Cordua, Nadia
    Smolenski, Ryszard T.
    Peters, Godefridus J.
    Dziadziuszko, Rafal
    Santoro, Armando
    Zucali, Paolo A.
    Giovannetti, Elisa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [37] PROPHYLACTIC IRRADIATION OF INTERVENTION SITES IN MALIGNANT PLEURAL MESOTHELIOMA
    Froment, M-A.
    Frechette, E.
    Dagnault, A.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S57 - S57
  • [38] Vinca alkaloids in the therapeutic management of malignant pleural mesothelioma
    Ceresoli, Giovanni Luca
    Zucali, Paolo Andrea
    CANCER TREATMENT REVIEWS, 2015, 41 (10) : 853 - 858
  • [39] An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
    Davis, Alexander
    Ke, Helen
    Kao, Steven
    Pavlakis, Nick
    LUNG CANCER-TARGETS AND THERAPY, 2022, 13 : 1 - 12
  • [40] The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma
    Oguh-Olayinka, Lily
    Agarwal, Vijay
    Ranatunge, Dulani
    Campbell, Anne
    Laufer, Stefan
    Cawkwell, Lynn
    Lind, Michael J.
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 985 - 995
12345